BR0314031A - Tratamento de rinite não-alérgica por inibidores seletivos de fosfodiesterase 4 - Google Patents

Tratamento de rinite não-alérgica por inibidores seletivos de fosfodiesterase 4

Info

Publication number
BR0314031A
BR0314031A BR0314031-8A BR0314031A BR0314031A BR 0314031 A BR0314031 A BR 0314031A BR 0314031 A BR0314031 A BR 0314031A BR 0314031 A BR0314031 A BR 0314031A
Authority
BR
Brazil
Prior art keywords
treatment
allergic rhinitis
phosphodiesterase inhibitors
selective phosphodiesterase
inhibitors
Prior art date
Application number
BR0314031-8A
Other languages
English (en)
Inventor
Chris Rundfeldt
Hildegard Kuss
Norbert Hoefgen
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elbion Ag filed Critical Elbion Ag
Publication of BR0314031A publication Critical patent/BR0314031A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"TRATAMENTO DE RINITE NãO-ALéRGICA POR INIBIDORES SELETIVOS DE FOSFODIESTERASE 4". A invenção refere-se ao uso de hidróxi-indolilglioxilamidas como inibidores de fosfodiesterase 4, para o tratamento de rinite não-alérgica.
BR0314031-8A 2002-09-06 2003-09-05 Tratamento de rinite não-alérgica por inibidores seletivos de fosfodiesterase 4 BR0314031A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10241407A DE10241407A1 (de) 2002-09-06 2002-09-06 Behandlung nicht allergischer Rhinitis durch selektive Phosphodiesterase 4-Hemmstoffe
PCT/EP2003/009895 WO2004022041A2 (de) 2002-09-06 2003-09-05 Behandlung nicht allergischer rhinitis durch selektive phosphodiesterase 4-hemmstoffe

Publications (1)

Publication Number Publication Date
BR0314031A true BR0314031A (pt) 2005-07-05

Family

ID=31724458

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314031-8A BR0314031A (pt) 2002-09-06 2003-09-05 Tratamento de rinite não-alérgica por inibidores seletivos de fosfodiesterase 4

Country Status (18)

Country Link
US (1) US20040116501A1 (pt)
EP (1) EP1534272A2 (pt)
JP (1) JP2005539058A (pt)
KR (1) KR20050034760A (pt)
CN (1) CN1678307A (pt)
AR (1) AR041172A1 (pt)
AU (1) AU2003271586A1 (pt)
BR (1) BR0314031A (pt)
CA (1) CA2497374A1 (pt)
DE (1) DE10241407A1 (pt)
HR (1) HRP20050310A2 (pt)
MX (1) MXPA05002437A (pt)
NO (1) NO20051468L (pt)
PL (1) PL375494A1 (pt)
RU (1) RU2005109939A (pt)
TW (1) TW200404777A (pt)
WO (1) WO2004022041A2 (pt)
ZA (1) ZA200501582B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1670787B1 (en) 2003-09-11 2012-05-30 iTherX Pharma, Inc. Cytokine inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
DE19818964A1 (de) * 1998-04-28 1999-11-04 Dresden Arzneimittel Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phospodiesterase 4 und Verfahren zu deren Herstellung
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань

Also Published As

Publication number Publication date
HRP20050310A2 (en) 2005-06-30
TW200404777A (en) 2004-04-01
NO20051468L (no) 2005-06-03
ZA200501582B (en) 2005-09-09
AR041172A1 (es) 2005-05-04
PL375494A1 (en) 2005-11-28
WO2004022041A2 (de) 2004-03-18
WO2004022041A3 (de) 2004-05-06
JP2005539058A (ja) 2005-12-22
CN1678307A (zh) 2005-10-05
AU2003271586A1 (en) 2004-03-29
MXPA05002437A (es) 2005-06-03
DE10241407A1 (de) 2004-03-18
US20040116501A1 (en) 2004-06-17
RU2005109939A (ru) 2005-09-10
EP1534272A2 (de) 2005-06-01
KR20050034760A (ko) 2005-04-14
CA2497374A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
BR0314059A (pt) Compostos heterocìclicos
NL300933I2 (nl) Letermovir
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
CR7728A (es) Nuevas quinazolinas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
TW200407320A (en) Macrocyclic compounds useful as pharmaceuticals
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
MXPA04002983A (es) Derivados de quinuclidina, procedimientos para prepararlos y sus usos como inhibidores del receptor muscar??nico m2 y/o m3.
GB0504828D0 (en) Therapeutic agents
GB0426313D0 (en) Therapeutic agents
ATE393764T1 (de) Polymorphe formen von valsartan
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
DE50208918D1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
PT1325011E (pt) Metodos e compostos para tratamento de doencas proliferativas
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
NO20015259D0 (no) Substituerte bisykliske heterosykler, fremgangsmåte for deres fremstilling og deres anvendelse som antifedme oghyperkolesterolemiske midler
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
ATE460938T1 (de) Morpholin-derivate zur verwendung als dopaminagonisten in der behandlung von u.a. sexueller dysfunktion
BR0206917A (pt) Uso de antagonistas de mglur5 para o tratamento de condições prurìticas
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
DK2845594T3 (da) Anvendelse af dihydroimidazoloner til behandlingen af hunde.
BRPI0417263A (pt) imidazopiridinas para uso como inibidores de secreção gástrica

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]